Literature DB >> 34003358

The rescue and selection of thermally stable type O vaccine candidate strains of foot-and-mouth disease virus.

Ya Gao1, Pinghua Li1, Xueqing Ma1, Xingwen Bai1, Pu Sun1, Ping Du1, Hong Yuan1, Yimei Cao1, Kun Li1, Yuanfang Fu1, Jing Zhang1, Huifang Bao1, Yingli Chen1, Zhiyong Li1, Zengjun Lu2, Zaixin Liu3, Dong Li4.   

Abstract

Inactivated foot-and-mouth disease virus (FMDV) vaccines have been used widely to control foot-and-mouth disease (FMD). However, the virions (146S) of this virus are easily dissociated into pentamer subunits (12S), which limits the immune protective efficacy of inactivated vaccines when the temperature is higher than 30 °C. A cold-chain system can maintain the quality of the vaccines, but such systems are usually not reliable in limited-resource settings. Thus, it is imperative to improve the thermostability of vaccine strains to guarantee the quality of the vaccines. In this study, four recombinant FMDV strains containing single or multiple amino acid substitutions in the structural proteins were rescued using a previously constructed FMDV type O full-length infectious clone (pO/DY-VP1). We found that single or multiple amino acid substitutions in the structural proteins affected viral replication to different degrees. Furthermore, the heat and acid stability of the recombinant viruses was significantly increased when compared with the parental virus. Three thermally stable recombinant viruses (rHN/DY-VP1Y2098F, rHN/DY-VP1V2090A-S2093H, and rHN/DY-VP1V2090A-S2093H-Y2098F) were prepared as inactivated vaccines to immunize pigs. Blood samples were collected every week to prepare sera, and a virus neutralization test showed that the substitutions S2093H and Y2098F, separately or in combination, did not affect the immunogenicity of the virus, but the Y2098F mutation increased the thermostability significantly (p < 0.05). Therefore, the rHN/DY-VP1Y2098F mutant should be considered for use in future vaccines.

Entities:  

Year:  2021        PMID: 34003358     DOI: 10.1007/s00705-021-05100-3

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  36 in total

1.  Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines.

Authors:  S J Cox; N Aggarwal; R J Statham; P V Barnett
Journal:  Vaccine       Date:  2003-03-28       Impact factor: 3.641

Review 2.  The pathogenesis and diagnosis of foot-and-mouth disease.

Authors:  S Alexandersen; Z Zhang; A I Donaldson; A J M Garland
Journal:  J Comp Pathol       Date:  2003-07       Impact factor: 1.311

Review 3.  Global FMD control--is it an option?

Authors:  Paul Kitching; Jef Hammond; Martyn Jeggo; Bryan Charleston; David Paton; Luis Rodriguez; Robert Heckert
Journal:  Vaccine       Date:  2006-11-09       Impact factor: 3.641

Review 4.  Vaccination against foot-and-mouth disease virus: strategies and effectiveness.

Authors:  Satya Parida
Journal:  Expert Rev Vaccines       Date:  2009-03       Impact factor: 5.217

5.  An increase in acid resistance of foot-and-mouth disease virus capsid is mediated by a tyrosine replacement of the VP2 histidine previously associated with VP0 cleavage.

Authors:  Angela Vázquez-Calvo; Flavia Caridi; Francisco Sobrino; Miguel A Martín-Acebes
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

6.  A physico-chemical sub-grouping of the mammalian picornaviruses.

Authors:  J F Newman; D J Rowlands; F Brown
Journal:  J Gen Virol       Date:  1973-02       Impact factor: 3.891

7.  Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus.

Authors:  T R Doel; W K Chong
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

Review 8.  Foot-and-mouth disease virus: a long known virus, but a current threat.

Authors:  F Sobrino; M Sáiz; M A Jiménez-Clavero; J I Núñez; M F Rosas; E Baranowski; V Ley
Journal:  Vet Res       Date:  2001 Jan-Feb       Impact factor: 3.683

9.  Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids.

Authors:  S Curry; C C Abrams; E Fry; J C Crowther; G J Belsham; D I Stuart; A M King
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

10.  The history of research in foot-and-mouth disease.

Authors:  Fred Brown
Journal:  Virus Res       Date:  2003-01       Impact factor: 3.303

View more
  1 in total

1.  Molecular characterization of a novel polymycovirus from the phytopathogenic fungus Setosphaeria turcica.

Authors:  Zhongnan Gao; Manyu Zhang; Tingting Yu; Xiaoyan Wang; Xin Wang; Hongliu An; Songbai Zhang; Minghong Liu; Shouguo Fang
Journal:  Arch Virol       Date:  2021-05-24       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.